#USA #AI Technology #Florida #Medtronic #Touch Surgery

A New Era in Surgery: Medtronic Unveils Touch Surgery™ Aide

In a significant leap for surgical technology, Medtronic (NYSE: MDT), a leader in healthcare innovation, is unveiling its groundbreaking Touch Surgery™ Aide at the forthcoming Society of Robotic Surgery (SRS) Annual Meeting, set to take place from July 23-26, 2026, in Florida. This next-generation computing platform is designed to provide real-time artificial intelligence support during surgical procedures, aiming to enhance precision and outcomes.

The Touch Surgery™ Aide stands out by being an AI-native platform built on NVIDIA's advanced computing infrastructure. It allows surgical teams to gain real-time insights and decision-making support during operations, thus driving a new era of surgical excellence. With the capacity to process surgical video and contextual information in real time, this platform promises to significantly streamline workflows in over 1,500 operating rooms globally.

Enhancing Surgical Efficiency

The Touch Surgery™ ecosystem connects every phase of the surgical journey—from pre-operative planning to intra-operative tele-mentoring and post-operative insights. By integrating these elements, the Touch Surgery™ Aide empowers surgeons with actionable insights, thereby improving case reviews and clinical decision-making processes. According to Jim Peichel, Chief Technology Officer at Medtronic, “Real-time AI represents a transformative advancement in healthcare, shifting from assisting the surgeon’s hand to enhancing team collaboration and efficiency.”

AI-Powered Applications

At the heart of the Touch Surgery™ Aide is the Instrument Exit Point (IEP) application, which has received FDA clearance. This innovative tool utilizes computer vision technology to provide visual alerts when surgical instruments are at risk of moving beyond the surgeon's line of sight. By acting as an early warning system during robotic procedures, the IEP application is a crucial step toward the deeper integration of AI into robotics in surgery.

The IEP application is expected to evolve to support laparoscopic surgeries as part of Medtronic's broader vision of expanding AI capabilities. With the Hugo™ robotic-assisted surgery system already gaining traction in urologic surgical procedures, the inclusion of Touch Surgery™ Aide further solidifies the platform's versatility and commitment to improving patient outcomes.

The Future of Surgical Technology

The Touch Surgery™ Aide doesn't just represent a standalone product; it aligns with Medtronic's ongoing commitment to advance surgical practice through technology. As George Murgatroyd, General Manager and Vice President of Digital Technologies at Medtronic, emphasizes, “Surgery stands at the brink of a generational transformation, driven by artificial intelligence and sophisticated computing capabilities.” He envisions a future where the integration of AI transforms surgical workflows, fortifying Medtronic's mission to provide accessible, top-tier care globally.

Medtronic continues to lead the charge in healthcare innovation, eagerly anticipating the potential of its new platform to redefine surgical practices and improve patient care. By harnessing the capabilities of AI, Medtronic aims to shape a future where surgical decisions are enhanced by real-time insights, ultimately enhancing the precision and predictability of operations for the benefit of all patients.

For more information on Medtronic and its innovative technologies, please visit Medtronic's official website.